Cargando…

Sensitivity, specificity, and accuracy of a liquid biopsy approach utilizing molecular amplification pools

Circulating cell-free DNA (cfDNA) has the potential to be a specific biomarker for the therapeutic management of lung cancer patients. Here, a new sequencing error-reduction method based on molecular amplification pools (MAPs) was utilized to analyze cfDNA in lung cancer patients. We determined the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Garcia, Jessica, Kamps-Hughes, Nick, Geiguer, Florence, Couraud, Sébastien, Sarver, Brice, Payen, Léa, Ionescu-Zanetti, Cristian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8144209/ https://www.ncbi.nlm.nih.gov/pubmed/34031447 http://dx.doi.org/10.1038/s41598-021-89592-8

Ejemplares similares

Paired Comparison of Routine Molecular Screening of Patient Samples with Advanced Non-Small Cell Lung Cancer in Circulating Cell-Free DNA Using Three Targeted Assays
por: Barthelemy, David, et al.
Publicado: (2023)

Profiling of circulating tumor DNA in plasma of non‐small cell lung cancer patients, monitoring of epidermal growth factor receptor p.T790M mutated allelic fraction using beads, emulsion, amplification, and magnetics companion assay and evaluation in future application in mimicking circulating tumor cells
por: Garcia, Jessica, et al.
Publicado: (2019)

Routine Molecular Screening of Patients with Advanced Non-SmallCell Lung Cancer in Circulating Cell-Free DNA at Diagnosis and During Progression Using OncoBEAM(TM)EGFR V2 and NGS Technologies
por: Garcia, Jessica, et al.
Publicado: (2021)

Embryonated Chicken Tumor Xenografts Derived from Circulating Tumor Cells as a Relevant Model to Study Metastatic Dissemination: A Proof of Concept
por: Rousset, Xavier, et al.
Publicado: (2022)

ERASE-Seq: Leveraging replicate measurements to enhance ultralow frequency variant detection in NGS data
por: Kamps-Hughes, Nick, et al.
Publicado: (2018)

Diagnostic Accuracy of Liquid Biopsy in Endometrial Cancer
por: Łukasiewicz, Marta, et al.
Publicado: (2021)

Circulating H3K27 Methylated Nucleosome Plasma Concentration: Synergistic Information with Circulating Tumor DNA Molecular Profiling
por: Grolleau, Emmanuel, et al.
Publicado: (2023)

Advancements in Focal Amplification Detection in Tumor/Liquid Biopsies and Emerging Clinical Applications
por: Arshadi, Aram, et al.
Publicado: (2023)

Clinical Applications of Liquid Biopsy in Prostate Cancer: From Screening to Predictive Biomarker
por: Ionescu, Filip, et al.
Publicado: (2022)

Liquid Biopsy and Tissue Biopsy Comparison with Digital PCR and IHC/FISH for HER2 Amplification Detection in Breast Cancer Patients
por: Xie, Suhong, et al.
Publicado: (2022)

Clinical utility of liquid biopsy for EGFR driver, T790M mutation and EGFR amplification in plasma in patients with acquired resistance to afatinib
por: Oya, Yuko, et al.
Publicado: (2021)

Targeted locus amplification to develop robust patient-specific assays for liquid biopsies in pediatric solid tumors
por: van Zogchel, Lieke M. J., et al.
Publicado: (2023)

Liquid biopsy based HER2 amplification status in gastric cancer patients indicates clinical response
por: Klein-Scory, Susanne, et al.
Publicado: (2023)

Cross-platform comparison for the detection of RAS mutations in cfDNA (ddPCR Biorad detection assay, BEAMing assay, and NGS strategy)
por: Garcia, Jessica, et al.
Publicado: (2018)

Evolving Clinical Utility of Liquid Biopsy in Gastrointestinal Cancers
por: Jacobson, Richard A., et al.
Publicado: (2019)

Translational Utility of Liquid Biopsies in Thyroid Cancer Management
por: Wijewardene, Ayanthi A., et al.
Publicado: (2021)

Potential clinical utility of liquid biopsies in ovarian cancer
por: Zhu, Jie Wei, et al.
Publicado: (2022)

Validation of liquid biopsy for ESR1-mutation analysis in hormone-sensitive breast cancer: a pooled meta-analysis
por: Najim, Omar, et al.
Publicado: (2023)

Personalized Therapy and Liquid Biopsy—A Focus on Colorectal Cancer
por: Christou, Niki, et al.
Publicado: (2021)

Liquid biopsy in lymphoma
por: Rossi, Davide, et al.
Publicado: (2019)

Liquid Biopsy in Glioblastoma
por: Ronvaux, Lorian, et al.
Publicado: (2022)

Liquid biopsy and glioblastoma
por: Eibl, Robert H., et al.
Publicado: (2023)

Comparison of conventional, amplification and bio-assay detection methods for a chronic wasting disease inoculum pool
por: McNulty, Erin, et al.
Publicado: (2019)

Accuracy of CCL20 expression level as a liquid biopsy-based diagnostic biomarker for ovarian carcinoma
por: Sakares, Watchara, et al.
Publicado: (2022)

Caught in the middle with multiple displacement amplification: the myth of pooling for avoiding multiple displacement amplification bias in a metagenome
por: Marine, Rachel, et al.
Publicado: (2014)

Liquid biopsy genotyping in lung cancer: ready for clinical utility?
por: Huang, Wei-Lun, et al.
Publicado: (2017)

The Utility of Repetitive Cell-Free DNA in Cancer Liquid Biopsies
por: Gezer, Ugur, et al.
Publicado: (2022)

Potential utility of miRNAs for liquid biopsy in breast cancer
por: Liu, Xiangrong, et al.
Publicado: (2022)

BloodPAC Data Commons for Liquid Biopsy Data
por: Grossman, Robert L., et al.
Publicado: (2021)

Liquid Biopsy in Squamous Cell Carcinoma of the Esophagus and of the Head and Neck
por: Iacob, Razvan, et al.
Publicado: (2022)

Origin-Dependent Inverted-Repeat Amplification: Tests of a Model for Inverted DNA Amplification
por: Brewer, Bonita J., et al.
Publicado: (2015)

Liquid Biopsy in Oral Cancer
por: Lousada-Fernandez, Fatima, et al.
Publicado: (2018)

Liquid Biopsy in Gastrointestinal Cancers
por: Saini, Aman, et al.
Publicado: (2018)

The liquid biopsy in lung cancer
por: Ansari, Junaid, et al.
Publicado: (2016)

Liquid biopsies for bladder cancer
por: Ward, Douglas G., et al.
Publicado: (2017)

Emerging concepts in liquid biopsies
por: Perakis, Samantha, et al.
Publicado: (2017)

Liquid Biopsy in Breast Cancer
por: Banys-Paluchowski, Maggie, et al.
Publicado: (2020)

Liquid biopsies and cancer omics
por: Amelio, Ivano, et al.
Publicado: (2020)

Liquid biopsies in myeloid malignancies
por: Abdulmawjood, Bilal, et al.
Publicado: (2019)

Liquid Biopsies in Lung Cancer
por: Kemper, Marcel, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_neaklckp38r7onfle4vaoi0qns